Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
PBYI > SEC Filings for PBYI > Form 8-K on 13-Dec-2011All Recent SEC Filings

Show all filings for PUMA BIOTECHNOLOGY, INC.



Entry into a Material Definitive Agreement, Financial Statements and Exh

Item 1.01 Entry Into A Material Definitive Agreement.

On December 7, 2011, Puma Biotechnology, Inc., a Delaware corporation (the "Company"), entered into an Office Lease (the "Lease") with CA-10880 Wilshire Limited Partnership, a Delaware limited partnership, for approximately 13,254 rentable square feet of office space in the building located at 10880 Wilshire Boulevard, Los Angeles, California 90024 for use as the Company's headquarters. The initial term of the Lease is for seven years and is expected to commence on or about December 19, 2011. The base rent will be approximately $44,400 per month during the first year and will increase each year during the initial term, up to approximately $53,000 per month during the seventh year. In addition, the Company has an option to extend the Lease for an additional five-year term, which would commence upon the expiration of the initial term. In the event the Company elects to extend the Lease, the minimum monthly rent payable for the additional term will be determined according to the then-prevailing market rate.

The foregoing summary of the Lease does not purport to be complete and is qualified in its entirety by reference to the full text of the Lease, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

10.1 Office Lease by and between Puma Biotechnology, Inc. and CA-10880 Wilshire Limited Partnership, executed on December 7, 2011

  Add PBYI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for PBYI - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.